We do have to realise there is a global shortage of rapid antigen tests. They are in short supply in the United Kingdom and United States, in Canada, right around the world. Because Omicron has resulted in this huge additional demand. Now, Australia still has one of the highest testing rates for population, per capita in the world. So we have, despite all of the pressures of Omicron, managed to maintain some of the highest rates of testing of any country in the world. We are, as I said before, procuring additional kits to support that additional capacity.
But amongst a global supply shortage there are pressures there. In terms of approvals for other kits to come on to the market, they are matters that the health authorities, the Therapeutic Goods Administration, work through carefully and obviously any kit that is going to be used needs to meet sufficiently high standards in term of its accuracy and efficacy to come on to the market and that testing of those kits is important in the first place.
